Filing Details
- Accession Number:
- 0001209191-19-019753
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-15 17:17:25
- Reporting Period:
- 2019-03-13
- Accepted Time:
- 2019-03-15 17:17:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
917520 | Integra Lifesciences Holdings Corp | IART | Surgical & Medical Instruments & Apparatus (3841) | 510317849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1187576 | E Richard Caruso | 795 E Lancaster Avenue, Suite 200 Villanova PA 19085 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-03-13 | 9,250 | $21.97 | 143,384 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-03-13 | 9,250 | $56.06 | 134,134 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-03-13 | 20,878 | $21.97 | 155,012 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-03-13 | 20,878 | $56.06 | 134,134 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-03-13 | 9,250 | $0.00 | 9,250 | $21.97 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-03-13 | 20,878 | $0.00 | 20,878 | $21.97 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,878 | 2019-05-17 | No | 4 | M | Direct | |
0 | 2019-05-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 11,982,410 | Indirect | By Partnership |
Common Stock | 4,000 | Indirect | By Son |
Footnotes
- 25% of the stock options vest every quarter from the grant date of 5/17/2011
- This option was previously reported as covering 4,431 shares at an exercise price of $50.78 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 4,625 shares of common stock at an exercise price of $43.93 per share.
- In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
- This option was previously reported as covering 10,000 shares at an exercise price of $50.78 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 10,439 shares of common stock at an exercise price of $43.93 per share.